SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (1150)10/21/1999 4:17:00 PM
From: Bo Didley  Read Replies (1) of 5582
 
Zicam is so big

this message board will have no influence over the price of the stock. The number 1 cold remedy in the $2.3 billion
cold market attracts institutions, not just individuals.
We don't need to rely on individuals trials of ZICAM, we have past research and about to be released second clinicals.

We are little investors compared to the future money that
will be adding GUMM to their mutual fund/Hedge Fund long term portfolios.

bo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext